178 related articles for article (PubMed ID: 12520637)
1. Capecitabine and radiation therapy for advanced gastrointestinal malignancies.
Rich T
Oncology (Williston Park); 2002 Dec; 16(12 Suppl No 14):27-30. PubMed ID: 12520637
[TBL] [Abstract][Full Text] [Related]
2. Capecitabine: a review.
Walko CM; Lindley C
Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
[TBL] [Abstract][Full Text] [Related]
3. Xeloda in colorectal cancer.
Cassidy J
Int J Clin Pract; 2001 Jun; 55(5):326-8. PubMed ID: 11452682
[TBL] [Abstract][Full Text] [Related]
4. Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy.
Rich TA; Shepard RC; Mosley ST
J Clin Oncol; 2004 Jun; 22(11):2214-32. PubMed ID: 15169811
[TBL] [Abstract][Full Text] [Related]
5. Can capecitabine replace 5-FU/leucovorin in combination with oxaliplatin for the treatment of advanced colorectal cancer?
Twelves C
Oncology (Williston Park); 2002 Dec; 16(12 Suppl No 14):23-6. PubMed ID: 12520636
[TBL] [Abstract][Full Text] [Related]
6. Capecitabine plus oxaliplatin for the treatment of colorectal cancer.
Carrato A; Gallego-Plazas J; Guillén-Ponce C
Expert Rev Anticancer Ther; 2008 Feb; 8(2):161-74. PubMed ID: 18279056
[TBL] [Abstract][Full Text] [Related]
7. The role of capecitabine in locally advanced rectal cancer treatment: an update.
Fernández-Martos C; Nogué M; Cejas P; Moreno-García V; Machancoses AH; Feliu J
Drugs; 2012 May; 72(8):1057-73. PubMed ID: 22621694
[TBL] [Abstract][Full Text] [Related]
8. ML17032 trial: capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in advanced gastric cancer.
Ryu MH; Kang YK
Expert Rev Anticancer Ther; 2009 Dec; 9(12):1745-51. PubMed ID: 19954285
[TBL] [Abstract][Full Text] [Related]
9. Development of and clinical experience with capecitabine (Xeloda) in the treatment of solid tumours.
Sternberg CN; Reichardt P; Holland M
Eur J Oncol Nurs; 2004; 8 Suppl 1():S4-15. PubMed ID: 15341878
[TBL] [Abstract][Full Text] [Related]
10. The use of capecitabine in the combined-modality therapy for rectal cancer.
Liauw SL; Minsky BD
Clin Colorectal Cancer; 2008 Mar; 7(2):99-104. PubMed ID: 18501068
[TBL] [Abstract][Full Text] [Related]
11. Capecitabine for the treatment of advanced gastric cancer.
Norman G; Soares M; Peura P; Rice S; Suh D; Wright K; Sculpher M; Eastwood A
Health Technol Assess; 2010 Oct; 14(Suppl. 2):11-7. PubMed ID: 21047486
[TBL] [Abstract][Full Text] [Related]
12. Evolution of 5-fluorouracil-based chemoradiation in the management of rectal cancer.
Patel PA
Anticancer Drugs; 2011 Apr; 22(4):311-6. PubMed ID: 21301320
[TBL] [Abstract][Full Text] [Related]
13. COX-2 inhibitors as radiation sensitizers for upper GI tract cancers: esophagus, stomach, and pancreas.
Rich TA; Shepard R
Am J Clin Oncol; 2003 Aug; 26(4):S110-3. PubMed ID: 12902867
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase.
Saif MW; Black G; Roy S; Bell D; Russo S; Eloubeidi MA; Steg A; Johnson MR; Zelterman D; Diasio RB
Cancer J; 2007; 13(4):247-56. PubMed ID: 17762760
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.
Krishnan S; Janjan NA; Skibber JM; Rodriguez-Bigas MA; Wolff RA; Das P; Delclos ME; Chang GJ; Hoff PM; Eng C; Brown TD; Crane CH; Feig BW; Morris J; Vadhan-Raj S; Hamilton SR; Lin EH
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):762-71. PubMed ID: 17011451
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism and possible biochemical modulation of capecitabine (Xeloda), a newly generated oral fluoropyrimidine].
Saeki T; Takashima S
Gan To Kagaku Ryoho; 1999 Mar; 26(4):447-55. PubMed ID: 10097741
[TBL] [Abstract][Full Text] [Related]
17. Capecitabine and radiotherapy as neoadjuvant treatment for rectal cancer.
Ben-Josef E
Am J Clin Oncol; 2007 Dec; 30(6):649-55. PubMed ID: 18091061
[TBL] [Abstract][Full Text] [Related]
18. Capecitabine: an overview of the side effects and their management.
Saif MW; Katirtzoglou NA; Syrigos KN
Anticancer Drugs; 2008 Jun; 19(5):447-64. PubMed ID: 18418212
[TBL] [Abstract][Full Text] [Related]
19. Review of capecitabine as oral treatment of gastric, gastroesophageal, and esophageal cancers.
Ajani J
Cancer; 2006 Jul; 107(2):221-31. PubMed ID: 16770784
[TBL] [Abstract][Full Text] [Related]
20. Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorin.
Hennig IM; Naik JD; Brown S; Szubert A; Anthoney DA; Jackson DP; Melcher AM; Crawford SM; Bradley C; Brown JM; Seymour MT
J Clin Oncol; 2008 Jul; 26(20):3411-7. PubMed ID: 18612156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]